Home > Boards > US OTC > Biotechs >

Galectin Therapeutics Inc. (GALT)

GALT RSS Feed
Add GALT Price Alert      Hide Sticky   Hide Intro
Moderator: stock_observer_77
Search This Board: 
Last Post: 3/18/2019 11:46:49 AM - Followers: 84 - Board type: Free - Posts Today: 0

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function.

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources.

Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer immunotherapy.
 

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Though we do not have any current marketed products, our research and development programs, designed to ultimately help patients and their physicians, are focused on:

 

Fibrosis

 

Fibrosis is the development of excess fibrous connective tissue in an organ when exposed to a chronic disease. The longer the disease affects the organ, the more fibrous tissue is deposited and this ultimately results in the failure of the organ. Galectin Therapeutics’ drug candidates provide a promising and exciting new approach for the treatment of fibrotic diseases, including liver, lung and kidney fibrosis. Significant unmet need exists for treatment options in fibrosis. For example, there are currently no approved medical treatments available for the millions of patients in the U.S. who have non-alcoholic steatohepatitis with advanced fibrosis – commonly known as fatty liver disease. Learn about fibrosis and our research in this area including galectin effects on liver fibrosis, lung fibrosis and kidney fibrosis.

 

Cancer

 

Cancer harms the body when damaged cells divide uncontrollably to form lumps or masses of tissue called tumors. Research shows the potential for galectin inhibition to play an important role in cancer therapy, particularly tumor immunotherapy – an emerging treatment that enhances the activity of the immune system against cancer cells. There are more than 100 types of cancers, and for many of these cancers, few treatment options exist. Our drug candidates provide a new and complimentary approach to other drugs on the market for the treatment of cancer. Learn more about cancer and immunotherapy.

 

GALT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GALT News: Securities Registration Statement (simplified Form) (s-3/a) 03/20/2019 05:18:52 PM
GALT News: Galectin Therapeutics Releases Richard E. Uihlein’s Open Letter to Stockholders 03/06/2019 08:03:00 AM
GALT News: Galectin Therapeutics Files Registration Statement for Stockholder Rights Offering of Common Stock and Warrants 03/06/2019 08:02:00 AM
GALT News: Galectin Therapeutics Reports Fiscal 2018 Financial Results and Provides Business Update 03/06/2019 08:00:00 AM
GALT News: Current Report Filing (8-k) 03/06/2019 07:59:09 AM
News News Alert: Securities Registration Statement (simplified Form) (s-3/a) 03/20/2019 05:18:52 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#3547   Huge news. The team that helped win 1234jklm 03/18/19 11:46:49 AM
#3546   Sounds like you've been here too long stock_observer_77 03/15/19 04:56:28 PM
#3545   Sure it’s necessary, but it’s a disappointment that buckysherm 03/15/19 01:58:28 PM
#3544   You have to consider if its adding value stock_observer_77 03/15/19 12:49:51 PM
#3543   FAKE NEWS... there's no Russian Dilutions going on superdodgeball 03/15/19 02:13:30 AM
#3542   Dilution isn’t really the relevant thing. It’s INFLATION buckysherm 03/12/19 08:34:44 PM
#3541   If every current owner purchases their pro rata Phantom Lord 03/08/19 02:34:00 PM
#3540   Of course there is dilution, they are issuing biotech2010 03/08/19 02:27:09 PM
#3539   But the offering is only available to existing Phantom Lord 03/08/19 09:36:01 AM
#3538   In Stock Twits they are trying to spin buckysherm 03/08/19 09:27:48 AM
#3537   I like that letter to the shareholders and thefamilyman 03/07/19 06:51:00 PM
#3536   Yes I was, not a surprise at all biotech2010 03/07/19 02:50:37 PM
#3535   Think about how many effing possible indication GRMD02 buckysherm 03/06/19 11:10:07 AM
#3534   Chairman adds $20M, and x10, all, are fully goingforittoday 03/06/19 10:37:04 AM
#3533   Looks like you are correct! stock_observer_77 03/06/19 08:52:57 AM
#3532   Richard E. Uihlein maintains that he intends to sokol 03/06/19 08:43:09 AM
#3530   That makes no sense, but to each his own stock_observer_77 03/04/19 03:01:32 PM
#3529   They've been actively looking for a partnership.buyout since biotech2010 03/04/19 02:42:09 PM
#3528   How do you know they struck out stock_observer_77 03/04/19 12:47:32 PM
#3527   Anyone who pays attention to the continual pumping biotech2010 03/04/19 12:45:53 PM
#3526   Gilead's Recent NASH Trial Failure Represents Opportunity For goingforittoday 02/19/19 09:47:57 PM
#3525   Today’s SA article may bump it up a buckysherm 02/15/19 09:33:39 AM
#3524   Good article Gilead's Mousetrap $GILD https://seekingalpha.com/article/4241397 Amatuer17 02/15/19 09:23:10 AM
#3523   Don’t be so sure. This move is based Amatuer17 02/15/19 06:30:31 AM
#3522   $5 break is imminent leading to higher highs stock_observer_77 02/15/19 01:25:35 AM
#3521   Thanks for this, I've been watching and holding heartofachild 02/14/19 12:32:24 AM
#3520   Price target $11 https://www.google.com/amp/s/www.smarteranalyst.com/brief/b-ril goingforittoday 02/13/19 08:41:38 AM
#3519   Oh sorry you mean drop in short interest stock_observer_77 01/27/19 05:21:16 AM
#3518   Short interest dropped almost 525,000 shares (12.7%) in mikeslife 01/26/19 07:16:41 PM
#3517   This is good article and the comment section Amatuer17 01/25/19 06:44:42 AM
#3516   Thanks stock_observer_77 01/24/19 07:51:39 PM
#3515   Good read Update On NASH Antifibrotics:Allergan Gilead goingforittoday 01/24/19 05:56:07 PM
#3514   True stock_observer_77 01/18/19 09:20:03 PM
#3513   But pretty much like last years ... as buckysherm 01/18/19 08:38:03 PM
#3512   Looks like they got options stock_observer_77 01/18/19 06:35:18 PM
#3511   What’s with all the Form 4’s ? buckysherm 01/18/19 06:25:39 PM
#3510   Thanks you too stock_observer_77 01/18/19 10:58:45 AM
#3509   Ten X would NOT give up their preferred buckysherm 01/18/19 10:56:20 AM
#3508   Quiet here stock_observer_77 01/18/19 04:58:53 AM
#3507   Up 40 cents on less than 40 K buckysherm 01/16/19 09:47:42 AM
#3506   No idea. I liked the news though. stock_observer_77 01/16/19 06:49:26 AM
#3505   I’m expecting this to drag on for months, buckysherm 01/15/19 11:24:38 PM
#3504   Still holding shares waiting for BO stock_observer_77 01/15/19 11:09:59 PM
#3503   B shares are being converted, this could be buckysherm 01/15/19 12:30:06 PM
#3502   From Yahoo Finance: mikeslife 01/14/19 07:50:37 AM
#3501   GALT is about to drop precipitously, because I buckysherm 01/13/19 09:06:10 PM
#3500   Up 10% on 17 K shares ? buckysherm 01/02/19 10:16:12 AM
#3499   On Stocktwits many of the posters are delusional mikeslife 01/02/19 09:49:59 AM
#3498   In here and Stock Twits, people are so buckysherm 01/02/19 08:22:08 AM
#3497   More updates means that he will continue to buckysherm 01/02/19 08:16:23 AM
PostSubject